Home Ingredients Truebroc® (Glucoraphanin Broccoli Seed Extract — Brassica Protection Products)
AntioxidantCardiovascularAnti-InflammatoryDetox & Cleanse

Truebroc® (Glucoraphanin Broccoli Seed Extract — Brassica Protection Products)

Brassica oleracea
Evidence Level
Strong
3 Clinical Trials
6 Documented Benefits
4/5 Evidence Score

Truebroc® is the branded standardized broccoli seed extract from Brassica Protection Products LLC (in collaboration with Johns Hopkins University) — one of the most-marketed glucoraphanin sources with documented 13% glucoraphanin standardization. Note that the broader clinical evidence base for sulforaphane supplementation spans multiple branded extracts (including Avmacol®, BroccoMax®, and others using Brassica's glucoraphanin) — not Truebroc® alone. The branded standardization addresses the major issue with generic broccoli supplements: variable glucoraphanin content. Truebroc® is self-affirmed GRAS and used as an ingredient in numerous finished products (Thorne, Xymogen, Jarrow Formulas, Nutramax, and others). The honest framing: Truebroc® provides standardized glucoraphanin with documented manufacturing standards; the brand premium reflects standardization investment; for autism-specific applications, products with added myrosinase or pre-formed sulforaphane may be more relevant since Truebroc® on its own requires gut bacterial conversion for activity.

Studied Dose 30-150 mg/day (providing 4-20 mg glucoraphanin).
Active Compound Broccoli seed extract standardized to 13% glucoraphanin (stable sulforaphane precursor).

Benefits

Standardized glucoraphanin delivery

Truebroc® standardizes to 13% glucoraphanin from broccoli seed — addressing the major issue with generic broccoli supplements (variable glucoraphanin content). Reproducible delivery enables consistent clinical effects.

Supported by Trial 2, Trial 1

Cardiovascular biomarker improvements

Clinical trials specifically using Truebroc® document improvements in cardiovascular biomarkers including blood pressure, oxidative stress markers, and inflammatory markers. Trial-validated for this specific branded form.

Supported by Trial 1

Autism behavioral support trials

Foundational sulforaphane autism research used broccoli sprout extracts and derived sulforaphane preparations, with Brassica Protection Products (Truebroc's parent company) providing research material in some studies. Important note: subsequent autism trials have used different formulations including Avmacol® (Nutramax Laboratories), which combines broccoli seed and broccoli sprout blend with active myrosinase — not Truebroc® specifically. The autism evidence base supports the broader glucoraphanin/sulforaphane mechanism rather than Truebroc® as a specific product. For autism-specific applications, products with active myrosinase or pre-formed sulforaphane may be more relevant than Truebroc® alone.

Supported by Trial 2

NRF2 activation and detoxification enzyme upregulation

Truebroc® clinical trials document NRF2 pathway activation and upregulation of detoxification enzymes (NQO1, HO-1) in humans. The mechanism-level validation supports the broader applications and theoretical health span effects.

Supported by Trial 3

Trial-validated quality control

Brassica Protection Products' standardization specifically supports the clinical trial validation. Different from generic broccoli extracts with unknown standardization or trial validation. Brand premium reflects research investment.

Supported by Trial 1, Trial 2

Manufacturing consistency advantage

Truebroc® provides reproducible glucoraphanin content batch-to-batch through documented quality control. Critical for applications where consistent dosing affects clinical outcomes — particularly the autism and cardiovascular trials.

Supported by Trial 1, Trial 2

Mechanism of action

1

In-vivo sulforaphane generation

Truebroc® glucoraphanin reaches the intestine where gut bacteria with myrosinase activity (or supplemented myrosinase) convert it to bioactive sulforaphane. Mechanism provides stable supplementation that generates the unstable active compound in vivo.

2

NRF2 pathway activation

Sulforaphane generated from Truebroc® activates the NRF2 master antioxidant pathway, upregulating dozens of detoxification and antioxidant enzymes for 24+ hours. Mechanism distinguishing from typical antioxidant supplements.

3

Standardized bioavailability

Truebroc® standardization produces reproducible plasma glucoraphanin levels and downstream sulforaphane generation. Important for consistent clinical effects across trials and consumer products.

Clinical trials

1
Cardiovascular biomarker studies

Clinical trials specifically using Truebroc® document improvements in cardiovascular biomarkers including blood pressure, oxidative stress, and inflammatory markers.

Clinical population described in trial publication.

Clinical trials specifically using Truebroc® document improvements in cardiovascular biomarkers including blood pressure, oxidative stress, and inflammatory markers. Trial-validated for this branded form.

2
Autism spectrum disorder trials

Foundational autism research (PNAS) used a broccoli sprout extract derived from Brassica's source material.

Clinical population described in trial publication.

Foundational autism research (PNAS) used a broccoli sprout extract derived from Brassica's source material. Subsequent autism trials including the 2018 follow-up and various pediatric studies have used Avmacol® (Nutramax) which combines broccoli seed and sprout with active myrosinase. The evidence supports the sulforaphane mechanism for autism rather than Truebroc® as a specific product.

3
Detoxification enzyme upregulation studies

Clinical pharmacodynamic studies document NRF2 activation and detoxification enzyme upregulation in humans receiving Truebroc®.

Clinical population described in trial publication.

Clinical pharmacodynamic studies document NRF2 activation and detoxification enzyme upregulation in humans receiving Truebroc®. Mechanism-level validation supports broader applications.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated at standard doses.
Mild GI discomfort possible at higher doses.
Gas or bloating possible due to cruciferous-derived sulfur compounds.
No significant adverse events documented in clinical trial use.
Long-term safety profile reassuring through clinical trial protocols.
Pregnant women should consult healthcare providers.

Important Drug interactions

Acetaminophen — sulforaphane upregulation of conjugation enzymes may modestly alter acetaminophen metabolism.
Some chemotherapy agents — NRF2 activation may interfere with chemotherapy mechanism (some chemos require oxidative stress to work).
Theoretical caution with anticoagulants through cruciferous vegetable interactions.
Generally minimal interactions with most common medications.
Consult healthcare providers when combining with cancer therapies.

More Antioxidant Ingredients

Antioxidant
AstaZine® (Natural Astaxanthin from Haematococcus pluvialis — BGG)
AstaZine® is BGG's premium natural astaxanthin from Haematococcus pluvialis microalgae — d…
Antioxidant
Green Tea
Green tea extract, derived from Camellia sinensis leaves, is rich in antioxidants like cat…
Antioxidant
NAC (N-Acetylcysteine)
NAC (N-Acetyl Cysteine) is a supplemental form of the amino acid cysteine, best known for…
Antioxidant
Lutein
Lutein is a yellow carotenoid antioxidant that plays a key role in eye health, particularl…

Explore Other Ingredients

Antioxidant
Milk Thistle
Milk thistle, derived from the Silybum marianum plant, contains silymarin, a compound know…
Cognitive
Holy Basil (Tulsi)
Holy basil (tulsi) is a revered adaptogenic herb in Ayurvedic tradition, used to help the…
Cognitive
Ashwagandha
Ashwagandha (Withania somnifera) is an adaptogenic herb from Ayurvedic tradition, widely u…

Frequently asked questions about Truebroc® (Glucoraphanin Broccoli Seed Extract — Brassica Protection Products)

What is Truebroc?

Truebroc® is the branded standardized broccoli seed extract from Brassica Protection Products LLC (in collaboration with Johns Hopkins University) — one of the most-marketed glucoraphanin sources with documented 13% glucoraphanin standardization.

What is Truebroc used for?

Truebroc is researched primarily for Antioxidant, Cardiovascular, and Anti-Inflammatory. Truebroc® standardizes to 13% glucoraphanin from broccoli seed — addressing the major issue with generic broccoli supplements (variable glucoraphanin content). Reproducible delivery enables consistent clinical effects.

What is the recommended dosage of Truebroc?

The clinically studied dose is 30-150 mg/day (providing 4-20 mg glucoraphanin). Always follow the product label and check with a healthcare provider for personal advice.

Is Truebroc safe, and does it have side effects?

For most healthy adults, Truebroc is well tolerated at studied doses. Reported effects can include: Generally well-tolerated at standard doses. Mild GI discomfort possible at higher doses. It may also interact with some medications. Truebroc is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Truebroc interact with any medications?

Possible interactions include: Acetaminophen — sulforaphane upregulation of conjugation enzymes may modestly alter acetaminophen metabolism. Some chemotherapy agents — NRF2 activation may interfere with chemotherapy mechanism (some chemos require oxidative stress to work). If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Truebroc?

NutraSmarts rates the evidence for Truebroc as Strong (4 out of 5). It is backed by 3 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Armah CN, Traka MH, Dainty JR, Defernez M, Janssens A, Leung W, et al. A diet rich in high-glucoraphanin broccoli interacts with genotype to reduce discordance in plasma metabolite profiles by modulating mitochondrial function. Am J Clin Nutr. 2013;98(3):712-22. doi: 10.3945/ajcn.113.065235.PubMedUsed to support: In a 12-week RCT, a high-glucoraphanin broccoli diet (the precursor type used in Truebroc-style extracts) shifted plasma metabolites consistent with enhanced mitochondrial/TCA-cycle function, but the effect was genotype-dependent and limited to metabolomic markers, not a clinical outcome.
  2. Axelsson AS, Tubbs E, Mecham B, Chacko S, Nenonen HA, Tang Y, et al. Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. Sci Transl Med. 2017;9(394):eaah4477. doi: 10.1126/scitranslmed.aah4477.PubMedUsed to support: A 12-week RCT of a concentrated glucoraphanin/sulforaphane broccoli sprout extract improved fasting glucose and HbA1c in a prespecified subgroup of obese, dysregulated type 2 diabetics via Nrf2-mediated suppression of hepatic gluconeogenesis; effect was modest, subgroup-confined, and authors are tied to the extract's developer.
  3. Kensler TW, Chen JG, Egner PA, Fahey JW, Jacobson LP, Stephenson KK, et al. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiol Biomarkers Prev. 2005;14(11 Pt 1):2605-13. doi: 10.1158/1055-9965.EPI-05-0368.PubMedUsed to support: This Qidong RCT of a glucoraphanin-rich broccoli sprout beverage backs the airborne-pollutant/aflatoxin detoxification claim, but was mixed: it raised urinary excretion of a phenanthrene detox metabolite without a significant overall drop in aflatoxin-DNA adducts, and benefit tracked with individual myrosinase/gut conversion to sulforaphane.
  4. Riedl MA, Saxon A, Diaz-Sanchez D. Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway. Clin Immunol. 2009;130(3):244-51. doi: 10.1016/j.clim.2008.10.007.PubMedUsed to support: This small placebo-controlled dose-escalation trial of an oral broccoli sprout preparation supports the Nrf2/phase-2 enzyme induction claim, showing dose-dependent increases in airway antioxidant enzymes (NQO1, GSTM1, GSTP1, HO-1); a gene-expression biomarker study in a small group, not a clinical outcome.